EUVIMEDEUVIMED entdecken
Editorial

Glucagon-like peptide-1 receptor agonists and aspiration risk

Daniel I McIsaac, Gregory L Bryson

BMJ · 22.10.2024 · q1986

DOI: 10.1136/bmj.q1986 ↗

Kurz gefasst

Editorial in der Zeitschrift BMJ, online erschienen am 22.10.2024. Verfasst von Daniel I McIsaac und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada dmcisaac@toh.ca. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Balancing the harms and risks of periprocedural management

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada dmcisaac@toh.ca.
  • Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada.

Zitieren

APA

McIsaac, D. I., & Bryson, G. L. (2024). Glucagon-like peptide-1 receptor agonists and aspiration risk. BMJ, q1986. https://doi.org/10.1136/bmj.q1986

Vancouver

McIsaac DI, Bryson GL. Glucagon-like peptide-1 receptor agonists and aspiration risk. BMJ. 2024:q1986. doi:10.1136/bmj.q1986

BibTeX
@article{McIsaac2024,
  author = {McIsaac, Daniel I and Bryson, Gregory L},
  title = {Glucagon-like peptide-1 receptor agonists and aspiration risk},
  journal = {BMJ},
  year = {2024},
  pages = {q1986},
  doi = {10.1136/bmj.q1986}
}
Kostenlos starten →